OncoBeta^® Rhenium-SCT^®

Painless Non-Invasive Skin Cancer Therapy

Painless

The Rhenium-SCT® is a painless therapy with no anaesthesia needed. Especially good for elderly patients, patients with allergies and patients with multiple morbidities or low tolerance to pain.

Single Session

The Rhenium-SCT® is a single-session treatment in most all cases.

Non-Invasive

The Rhenium-SCT® is a medical procedure which is non-invasive. A procedure is considered non-invasive when no break or cut in the skin is created. This means no stitches or the possibility of secondary infection.

Personalised

The Rhenium-SCT® is a precise, personalised therapy that is only applied to the area needed to treat. This means that no unnecessary healthy tissue is damaged either in the depth or outside of the safety border.

Short Treatment Duration

Easy and practical thank the simple application and short treatment duration.

Aesthetic

Sensational aesthetic results with little or no scarring, considerably fast healing period, no stress treatment, restored functionality.

What is Rhenium-188?

Rhenium-188 is an isotope that emits ß-radiation, which has excellent therapeutic advantages.

ß-radiation is the emission of ß-particles, which can penetrate the human tissue only up to 2-3 mm deep. Therefore, rhenium-188 is ideal in treating superficial tissue without affecting other parts of the body.

It has a half-life of 17 hours, which means that the radioactivity decays up to the half in 17 hours while emitting ß-radiation. This allows treatments to be performed in a very short period of time.

The Rhenium-188 Compound

Rhenium-188 is bound to a fluid matrix or “compound” in order to enable an application precisely over the tumour.

The Rhenium-188-Compound is filled in so called carpoules which include a specially designed brush for precise application.

The Carpoules are loaded into the special Oncobeta® applicator for safe handling and efficient usage.

The lesion or the area needed to treat is first covered with a special protective foil.

During the Rhenium-SCT®, the physician is able to apply the exact needed amount of the Rhenium-188-Compound accurately and efficiently utilizing the specifically developed mechanical control. This way the compound is applied homogeneously and precisely over the tumor or area needed to treat.

Which cases can be treated with Rhenium-SCT®?

The Rhenium-SCT® is approved in Europe, South Africa and Australia for the treatment of basal and squamous cell carcinomas of the skin.

In general, the Rhenium-SCT® can be applied to any location on the body. It can be applied to single and/or multiple lesions of almost any shape or size in just one session.

It is also suitable for patients of any age as well as patients with previously treated or complicated lesions.

The Rhenium-SCT® is not recommended for minors or pregnant patients.